These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7381127)

  • 1. Immunotherapy.
    Bookman R
    J Allergy Clin Immunol; 1980 Jul; 66(1):89. PubMed ID: 7381127
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose dependence of Hymenoptera venom immunotherapy.
    Golden DB; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
    J Allergy Clin Immunol; 1981 May; 67(5):370-4. PubMed ID: 7229226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy.
    Morris DL; Sabnis VK; Kroker GF; Morris MS
    Ann Allergy Asthma Immunol; 2000 Dec; 85(6 Pt 1):514. PubMed ID: 11152177
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.
    Ewbank PA; Murray J; Sanders K; Curran-Everett D; Dreskin S; Nelson HS
    J Allergy Clin Immunol; 2003 Jan; 111(1):155-61. PubMed ID: 12532112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of allergen immunotherapy: a review of premedication and dose adjustment.
    Morris AE; Marshall GD
    Immunotherapy; 2012 Mar; 4(3):315-22. PubMed ID: 22401636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New concepts in immunotherapy.
    Willoughby JW
    Otolaryngol Clin North Am; 1992 Feb; 25(1):71-100. PubMed ID: 1549390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy, can we improve it?
    Waldbott GL
    Ann Allergy; 1980 Jul; 45(1):56-8. PubMed ID: 7406243
    [No Abstract]   [Full Text] [Related]  

  • 8. Standards for practical allergen-specific immunotherapy.
    Alvarez-Cuesta E; Bousquet J; Canonica GW; Durham SR; Malling HJ; Valovirta E;
    Allergy; 2006; 61 Suppl 82():1-20. PubMed ID: 16930249
    [No Abstract]   [Full Text] [Related]  

  • 9. An overview of immunotherapy: implications for the future.
    Norman PS
    J Allergy Clin Immunol; 1980 Feb; 65(2):87-96. PubMed ID: 6153189
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose response of IgE and IgG antibodies during ragweed immunotherapy.
    Creticos PS; Van Metre TE; Mardiney MR; Rosenberg GL; Norman PS; Adkinson NF
    J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):94-104. PubMed ID: 6607272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour microenvironment studies open new perspectives for immunotherapy.
    Verloes R; Kanarek L
    Arch Int Physiol Biochim; 1976 Apr; 84(2):420-2. PubMed ID: 71078
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy: first do no harm.
    Moss MH
    Immunol Allergy Clin North Am; 2005 May; 25(2):421-39, viii. PubMed ID: 15878464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of side effects of specific immunotherapy by premedication with antihistaminics and reduction of maximal dosage to 50.000 SQ-U/ml.
    Jarisch R; Götz M; Aberer W; Sidl R; Stabel A; Zajc J; Fördös A
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):163-75. PubMed ID: 2904241
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-2 activated cytotoxic lymphocytes and their application in the intraoperative immunotherapy of local tumors.
    Grimm EA
    Prog Clin Biol Res; 1987; 244():185-95. PubMed ID: 3498948
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of venom immunotherapy administered by a cluster schedule.
    Tarhini H; Knani J; Michel FB; Bousquet J
    J Allergy Clin Immunol; 1992 Jun; 89(6):1198-9. PubMed ID: 1607554
    [No Abstract]   [Full Text] [Related]  

  • 17. Sublingual immunotherapy.
    Frew AJ; Smith HE
    J Allergy Clin Immunol; 2001 Mar; 107(3):441-4. PubMed ID: 11240942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of conventional immunotherapy in southern California.
    Nagaya H
    Ann Allergy; 1980 Apr; 44(4):193-9. PubMed ID: 6154434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy of malignant diseases using interleukin 2. Bases, results, trends].
    Gause A; Pfreundschuh M
    Med Klin (Munich); 1990 Sep; 85(9):561-6, 570. PubMed ID: 2233615
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-injection routes for immunotherapy of allergic diseases.
    Valovirta E; Passalacqua G; Canonica WG
    Clin Allergy Immunol; 2004; 18():607-23. PubMed ID: 15042938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.